Literature DB >> 20605479

LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses.

Richard L Klein1, Rickey E Carter, Alicia J Jenkins, Timothy J Lyons, Nathaniel L Baker, Gregory E Gilbert, Gabriel Virella, Maria F Lopes-Virella.   

Abstract

Immune complexes containing modified LDL (LDL-IC) and NMR-determined Total LDL particle concentrations are significantly associated with intima-media thickness (IMT). We analyzed the associations between concentrations of NMR-determined lipoprotein subclasses and LDL-IC in the DCCT/EDIC cohort. LDL-IC concentrations in women and men of the DCCT/EDIC cohort did not differ significantly and were positively associated with Total LDL particle concentrations in men and women (r=0.34, r=0.32, respectively; P<.01) and with Small LDL concentration (r=0.22, r=0.13, respectively; P<.01). In women, Large LDL concentrations were also associated with LDL-IC (r=0.20, P<.01) while in men, the association was more modest (r=0.11, P<.05). Thus, both Small and Large LDL are associated with LDL-IC formation. Based on the results from statistical mediation analyses, we concluded that plasma concentrations of LDL-IC may provide a physiological link between the statistically significant association of Total LDL particle concentration with carotid artery IMT in subjects with Type 1 diabetes. Furthermore, after adjusting for conventional risk factors, there was a decrease in LDL-IC concentration even in the presence of high Total LDL particle concentrations in those women with high concentrations of Large HDL, but the association was not evident in men. This suggests that the associations between Large HDL and Total LDL particle concentrations, and their associations with LDL-IC levels, differ by gender and suggest that LDL-IC partially mediate the contribution of Total LDL particle concentration to increased carotid IMT in diabetic men. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605479      PMCID: PMC2978771          DOI: 10.1016/j.jdiacomp.2010.03.001

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  27 in total

1.  A comparison of methods to test mediation and other intervening variable effects.

Authors:  David P MacKinnon; Chondra M Lockwood; Jeanne M Hoffman; Stephen G West; Virgil Sheets
Journal:  Psychol Methods       Date:  2002-03

Review 2.  Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy.

Authors:  James D Otvos
Journal:  Clin Lab       Date:  2002       Impact factor: 1.138

3.  Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL.

Authors:  G Virella; D Atchley; Sinikka Koskinen; D Zheng; Maria F Lopes-Virella
Journal:  Clin Immunol       Date:  2002-10       Impact factor: 3.969

4.  The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor.

Authors:  M F Lopes-Virella; N Binzafar; S Rackley; A Takei; M La Via; G Virella
Journal:  Atherosclerosis       Date:  1997-12       Impact factor: 5.162

Review 5.  Glycoxidation and lipoxidation in atherogenesis.

Authors:  J W Baynes; S R Thorpe
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

6.  Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia.

Authors:  Alicia J Jenkins; Timothy J Lyons; Deyi Zheng; James D Otvos; Daniel T Lackland; Daniel McGee; W Timothy Garvey; Richard L Klein
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

7.  Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.

Authors:  Alicia J Jenkins; Timothy J Lyons; Deyi Zheng; James D Otvos; Daniel T Lackland; Daniel McGee; W Timothy Garvey; Richard L Klein
Journal:  Kidney Int       Date:  2003-09       Impact factor: 10.612

8.  Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

Authors:  David M Nathan; John Lachin; Patricia Cleary; Trevor Orchard; David J Brillon; Jye-Yu Backlund; Daniel H O'Leary; Saul Genuth
Journal:  N Engl J Med       Date:  2003-06-05       Impact factor: 91.245

Review 9.  The role of immune and inflammatory processes in the development of macrovascular disease in diabetes.

Authors:  Maria F Lopes-Virella; Gabriel Virella
Journal:  Front Biosci       Date:  2003-09-01

10.  Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

Authors:  Timothy J Lyons; Alicia J Jenkins; Deyi Zheng; Daniel T Lackland; Daniel McGee; W Timothy Garvey; Richard L Klein
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-03       Impact factor: 4.799

View more
  6 in total

Review 1.  Cardiovascular disease risk in young people with type 1 diabetes.

Authors:  Janet K Snell-Bergeon; Kristen Nadeau
Journal:  J Cardiovasc Transl Res       Date:  2012-04-12       Impact factor: 4.132

2.  Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes.

Authors:  Maria F Lopes-Virella; Nathaniel L Baker; Kelly J Hunt; John Lachin; David Nathan; G Virella
Journal:  Atherosclerosis       Date:  2010-11-17       Impact factor: 5.162

Review 3.  Cardiovascular function/dysfunction in adolescents with type 1 diabetes.

Authors:  Kristen J Nadeau; Jane E B Reusch
Journal:  Curr Diab Rep       Date:  2011-06       Impact factor: 4.810

Review 4.  Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.

Authors:  Alexander N Orekhov; Yuri V Bobryshev; Igor A Sobenin; Alexandra A Melnichenko; Dimitry A Chistiakov
Journal:  Int J Mol Sci       Date:  2014-07-21       Impact factor: 5.923

5.  Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect.

Authors:  Gerd Hörl; Harald Froehlich; Ulrika Ferstl; Gerhard Ledinski; Josepha Binder; Gerhard Cvirn; Tatjana Stojakovic; Michael Trauner; Christoph Koidl; Erwin Tafeit; Karin Amrein; Hubert Scharnagl; Günther Jürgens; Seth Hallström
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

6.  Serum urate and cardiovascular events in the DCCT/EDIC study.

Authors:  Alicia J Jenkins; Barbara H Braffett; Arpita Basu; Ionut Bebu; Samuel Dagogo-Jack; Trevor J Orchard; Amisha Wallia; Maria F Lopes-Virella; W Timothy Garvey; John M Lachin; Timothy J Lyons
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.